Physician profile
Vincente E Font
NPI 1164490819
$579.20
in general payments reported to CMS, 2019-2025
14 companies · $24.90 in 2025
The $24.90 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.78 · 2020: $30.78 · 2021: $73.88 · 2022: $102 · 2023: $157 · 2024: $140 · 2025: $24.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $321.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $133.76 | 2020-2023 | Lifevest |
| Boston Scientific Corporation | $60.66 | 2023-2024 | Watchman Flx |
| Novartis Pharmaceuticals Corporation | $57.09 | 2023-2024 | |
| Edwards Lifesciences Corporation | $51.55 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $39.64 | 2024 | Camzyos |
| Cvrx, INC. | $37.00 | 2023 | Barostim Neo System |
| Abbott Laboratories | $36.04 | 2021-2022 | |
| Lantheus Medical Imaging, INC. | $35.74 | 2022 | |
| Heartflow, INC. | $31.73 | 2024 | |
| Ge Healthcare | $24.90 | 2025 | |
| Sanofi-Aventis U.S. LLC | $21.17 | 2019 | |
| Amgen INC. | $20.31 | 2020 | |
| Amarin Pharma, INC. | $16.01 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincente Font listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.